John Corboy, MD, MA
Professor, Neurology

Download CV
Medical School:
  • MD, University of Pennsylvania School of Medicine (1985)
Graduate School :
  • MA, University of California, Los Angeles (1978)
Undergraduate School:
  • BA, University of Pennsylvania (Philadelphia, PA) (1976)
  • University of Pennsylvania Program (1986)
  • University of Pennsylvania Health System Program, Chief Resident, Psychiatry (1989)
  • Johns Hopkins University Program, Neurovirology (1992)
Languages: English
Department: Neurology

Professional Titles

  • Charles Elliot Morris Chair in Neurology
  • Executive Vice Chair of Neurology
  • Co-Director, Rocky Mountain Multiple Sclerosis Center at Anschutz Medical Campus
  • Director, Neuroimmunology/MS Fellowship

Research Interests

Clinical research in MS and related disorders


  • Professor (1994)
    School of Medicine, Neurology
    Multiple sclerosis, Neuroimmunology


  • Vollmer BL, Wallach AI, Corboy JR, Dubovskaya K, Alvarez E, Kister I. Serious safety events in rituximab-treated multiple sclerosis and related disorders.Ann Clin Transl Neurol. 2020 Aug 6. doi: 10.1002/acn3.51136. Online ahead of print. PMID: 32767531
  • Vollmer BL, Nair K, Sillau S, Corboy JR, Vollmer T, Alvarez E. Rituximab versus natalizumab, fingolimod, and dimethyl fumarate in multiple sclerosis treatment. Ann Clin Transl Neurol. 2020 Aug 6. doi: 10.1002/acn3.51111. Online ahead of print. PMID: 32767538
  • Cree BAC, Goldman MD, Corboy JR, Singer BA, Fox EJ, Arnold DL, Ford C, Weinstock-Guttman B, Bar-Or A, Mientus S, Sienkiewicz D, Zhang Y, Karan R, Tenenbaum N; Efficacy and Safety of 2 Fingolimod Doses vs Glatiramer Acetate for the Treatment of Patients With Relapsing-Remitting Multiple Sclerosis: A Randomized Clinical Trial. ASSESS Trial Investigators. JAMA Neurol. 2020 Aug 24:e202950. doi: 10.1001/jamaneurol.2020.2950. Online ahead of print.PMID: 32852530
  • Wu Q, Mills EA, Wang Q, Dowling CA, Fisher C, Kirch B, Lundy SK, Fox DA, Mao- Draayer Y. Siponimod enriches regulatory T and B lymphocytes in secondary progressive multiple sclerosis.; AMS04 Study Group.JCI Insight. 2020 Feb 13;5(3). pii: 134251. doi: 10.1172/jci.insight.134251. PMID: 31935197
  • Cree BAC, Cutter G, Wolinsky JS, et al SPI2 investigative teams. Safetyand efficacy of MD1003 (high-dose biotin) in patients with progressive multiple sclerosis (SPI2): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Neurol. 2020 Dec;19(12):988-997. doi: 10.1016/S1474-4422(20)30347-1. Epub 2020 Oct 23.PMID: 33222767
  • Waid DM, Schreiner T, Vaitaitis G, Carter JR, Corboy JR, Wagner DH Jr. Defining a new biomarker for the autoimmune component of Multiple Sclerosis: Th40 cells. J Neuroimmunol. 2014 Mar 15. [Epub ahead of print] PubMed PMID: 24690203
  • Lafosse JM, Mitchell SM, Corboy JR, Filley CM. The nature of verbal memory impairment in multiple sclerosis: a list-learning and meta-analytic study. J Int Neuropsychol Soc. 2013 Oct;19(9):995-1008. PubMed PMID: 24059259
  • Mattson DH, Lisak RP, Jones DE, Corboy JR, Larson R, Gronseth G, Getchius TS, Langer-Gould A, Langer-Gould AM, Gronseth GS, Larson R, Getchius TS. The American Academy of Neurology's top five Choosing Wisely recommendations. Neurology. 2013 Sep 10;81(11):1022-3. PubMed PMID: 24019388
  • Campbell JD, McQueen RB, Miravalle A, Corboy JR, Vollmer TL, Nair K. Comparative effectiveness of early natalizumab treatment in JC virus-negative relapsing-remitting multiple sclerosis. Am J Manag Care. 2013 Apr;19(4):278-85. PubMed PMID: 23725360
  • Hebert JR, Corboy JR. The association between multiple sclerosis-related fatigue and balance as a function of central sensory integration. Gait Posture. 2013 May;38(1):37-42. PubMed PMID: 23200463
View All (10 Total) View Less

Professional Memberships

  • American Neurological Association, Elected Member
  • Colorado Society of Clinical Neurologists, 1995-1997 Secretary/Treasurer
  • American Academy of Neurology, Fellow 2003

Practice Locations

Neurosciences Center - Anschutz
1635 Aurora Ct
4th Floor
Aurora, CO 80045

UCH - Anschutz Outpatient Pavilion
1635 Aurora Ct
Aurora, CO 80045

Hospital Affiliation
  • University of Colorado Hospital
Center Affiliations

Specialty Information

  • Neurology, Board Certification (1990)
  • Neuroimmunology
Conditions & Treatments
  • Brain and Nervous System
  • Brain and Nervous System - Multiple Sclerosis
Clinical Interests
Multiple Sclerosis, other neuroimmunological disorders, HIV in Nervous System, Infections and Inflammatory Disorders of the Central Nervous System

Care Philosophy
Multidisciplinary care for MS and related diseases. We believe in aggressive treatment of MS with disease modifying and symptomatic therapies.

Personal Interests
Skiing, golf, ice hockey, travel.

Volunteer Activities
Board member, National MS Society, Colorado-Wyoming Chapter Volunteer MS clinic at Denver Health Medical Center Advocacy at State and National level for access to health care

Public Speaking
MS Education at multiple levels

General Information

Medical Schools:
  • MD, University of Pennsylvania School of Medicine (1985)
Graduate Schools:
  • MA, University of California, Los Angeles (1978)
Undergraduate Schools:
  • BA, University of Pennsylvania (Philadelphia, PA) (1976)
  • University of Pennsylvania Program (1986)
Residency Programs:
  • University of Pennsylvania Health System Program, Chief Resident, Psychiatry (1989)
  • Johns Hopkins University Program, Neurovirology (1992)
Download CV
Languages: English
Department: Neurology